BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Peng J, Zhao S, Zhong Y, Wang Y, Hu J, Zhang C, Cheng M, Xia G, Hu Y, Huang K, Wang Y, Liang M. Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway. Front Pharmacol 2019;10:764. [PMID: 31333473 DOI: 10.3389/fphar.2019.00764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Yin Z, Chen X, Jiang G, Yang D, Cao Z, Li S, Liu Z, Peng D, Dou P. Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways. Front Pharmacol 2020;11:385. [PMID: 32317967 DOI: 10.3389/fphar.2020.00385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhou J, Yang RP, Song W, Xu HM, Wang YH. Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets. Front Med (Lausanne) 2020;7:380. [PMID: 32850895 DOI: 10.3389/fmed.2020.00380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ryoo GH, Moon YJ, Choi S, Bae EJ, Ryu JH, Park BH. Tussilagone promotes osteoclast apoptosis and prevents estrogen deficiency-induced osteoporosis in mice. Biochem Biophys Res Commun 2020;531:508-14. [PMID: 32807498 DOI: 10.1016/j.bbrc.2020.07.083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lin H, Chen M, Gao Y, Wang Z, Jin F. Tussilagone protects acute lung injury from PM2.5 via alleviating Hif-1α/NF-κB-mediated inflammatory response. Environ Toxicol 2022. [PMID: 35112795 DOI: 10.1002/tox.23476] [Reference Citation Analysis]
5 Zhang P, Lai X, Zhu MH, Long M, Liu XL, Wang ZX, Zhang Y, Guo RJ, Dong J, Lu Q, Sun P, Fang C, Zhao M. Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway. Front Pharmacol 2021;12:713200. [PMID: 34776948 DOI: 10.3389/fphar.2021.713200] [Reference Citation Analysis]
6 Chen S, Dong L, Quan H, Zhou X, Ma J, Xia W, Zhou H, Fu X. A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot). J Ethnopharmacol 2021;267:113478. [PMID: 33069788 DOI: 10.1016/j.jep.2020.113478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dos Santos TM, Righetti RF, Rezende BG, Campos EC, Camargo LDN, Saraiva-Romanholo BM, Fukuzaki S, Prado CM, Leick EA, Martins MA, Tibério IFLC. Effect of anti-IL17 and/or Rho-kinase inhibitor treatments on vascular remodeling induced by chronic allergic pulmonary inflammation. Ther Adv Respir Dis 2020;14:1753466620962665. [PMID: 33357114 DOI: 10.1177/1753466620962665] [Reference Citation Analysis]